Characterization and sensitivity to interleukin 2 and interferon α of leukemic cells from a patient with large granular lymphocytic leukemia associated with chronic active Epstein-Barr virus infection

Leukemia Research

Volumn 21, Issue 10, 1997, Pages 941-950

  Toba, Ken ^a   Koike, Tadashi ^a   Takahashi, Masuhiro ^a,b   Kishi, Kenji ^a   Hashimoto, Shigeo ^a   Takahashi, Hoyu ^a   Uesugi, Yumiko ^a   Ishikawa, Toru ^a   Aoki, Sadao ^a   Maeo, Syougo ^a   Naito, Makoto ^a   Aizawa, Yoshifusa ^a   Shibata, Akira ^c  

^a NIIGATA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY   (Japan)

^c Nagaoka Tachikawa Sogo Hospital   (Japan)

Author keywords

7AAD PY; Epstein Barr virus; Granular lymphocytic leukemia; Hemophagocytic syndrome; Interferon ; Interleukin 2; Mosquito allergy

Indexed keywords

ACICLOVIR; ALPHA INTERFERON; ETOPOSIDE; INTERLEUKIN 2; METHYLPREDNISOLONE; VINCRISTINE;

ADOLESCENT; ARTICLE; CASE REPORT; CAUSE OF DEATH; CELL CYCLE; DRUG SENSITIVITY; EPSTEIN BARR VIRUS; FEMALE; HUMAN; HUMAN CELL; INTERSTITIAL PNEUMONIA; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LARGE GRANULAR LYMPHOCYTE; LIVER DYSFUNCTION; LYMPHATIC LEUKEMIA; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY FAILURE; VIRUS CARCINOGENESIS; VIRUS CELL TRANSFORMATION; VIRUS INFECTION;

ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; CELL CYCLE; DNA, VIRAL; FEMALE; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 4, HUMAN; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-2; LEUKEMIA, LYMPHOCYTIC; PHENOTYPE; TUMOR CELLS, CULTURED; TUMOR VIRUS INFECTIONS;

EID: 0030829731     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(97)00057-X     Document Type: Article

References (45)

1. Tobi, M., Morag, A., Ravid, Z., Chowers, I., Feldman-Weiss, V., Michaeli, Y., Ben-Chetrit, E., Shalit, M. and Knobler, H., Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection. Lancet, 1982, i, 61.
2. Straus, S. E., Tosato, G., Armstrong, G., Lawley, T., Preble, O. T., Henle, W., Davey, R., Pearson, G., Epstein, J. and Brus, I., Persisting illness and fatigue in adults with evidence of Epstein-Barr virus infection. Annals of Internal Medicine, 1985, 102, 7.
3. Schooley, R. T., Carey, R. W., Miller, G., Henle, W., Eastman, R., Mark, E. J., Kenyon, K., Wheeler, E. O. and Rubin, R. H., Chronic Epstein-Barr virus infection associated with fever and interstitial pneumonitis: clinical and serologic features and response to antiviral chemotherapy. Annals of Internal Medicine, 1986, 104, 636.
4. Sheridan, W., Winton, E. F., Chan, W. C., Gordon, D. S., Vogler, W. R., Phillips, C., Bongiovanni, K. F. and Waldmann, T. A., Leukemia of non-T lineage natural killer cells. Blood, 1988, 72, 1701.
5. Pandolfi, F., Loughran, T. P., Starkebaum, G., Chisesi, T., Barbui, T., Chan, W. C., Brouet, J. C., de Rossi, G., McKenna, R. W., Salsano, F., Herrmann, F., vanOostveen, J. W., Schlimok, G., Cafaro, A., Zambello, R., Garcia Rodriguez, M. C., Geisler, C. H., Pizzolo, G., Steis, R. G., Brisbane, J. U., Kadin, M. E., Mantovani, A., Tagawa, S., Fauci, A. S., Gastl, G., Palutke, M., Proctor, S. J., Pross, H. F., Mancici, P., Aiuti, F. and Semenzato, G., Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes: a multicenter study. Cancer, 1990, 65, 341.
6. Oshimi, K., Yamada, O., Kaneko, T., Nishinarita, S., Iizuka, Y., Urabe, A., Inamori, T., Asano, S., Takahashi, S., Hattori, M., Naohara, T., Ohira, Y., Togawa, A., Masuda, Y., Okubo, Y., Furusawa, S., Sakamoto, S., Omine, M., Mori, M., Tatsumi, E. and Mizoguchi, H., Laboratory findings and clinical courses of 33 patients with granular lymphocyte-proliferative disorders [review]. Leukemia, 1993, 7, 782.
7. Sullivan, J. L., Woda, B. A., Herrod, H. G., Koh, G., Rivara, F. P. and Mulder, C., Epstein-Barr virus-associated hemophagocytic syndrome: virological and immunopathological studies. Blood, 1985, 65, 1097.
8. Ross, C. W., Schnitzer, B., Weston, B. W. and Hanson, C. A., Chronic active Epstein-Barr virus infection and virus-associated hemophagocytic syndrome. Archives of Pathology and Laboratory Medicine, 1991, 115, 470.
9. Miyashita, T., Kawaguchi, H., Mizutani, S. and Tsuchida, M., Histiocytic medullary reticulosis, a lethal form of Epstein-Barr virus related disorder. Lancet. 1991, 337, 986.
10. Fujisaki, T., Nagafuchi, S., Niho, Y., Tsuneyoshi, M., Oshima, K. and Kikuchi, M., Malignant histiocytosis in a patient with chronic active Epstein-Barr virus infection. Lancet, 1992, 340, 1168.
11. Randhawa, P. S., Demetris, J. and Nalesnik, M. A., EBER gene expression in Epstein-Barr virus-associated hematopoietic neoplasms. Leukemia and Lymphoma, 1994, 13, 387.
12. Niedobitek, G. and Young, L. S., Epstein-Barr virus persistence and virus-associated tumors. Lancet, 1994, 343, 333.
13. Knecht, H., Odermatt, B. F., Bachmann, E., Teixeira, S., Sahli, R., Hayoz, D., Heitz, P. and Bachmann, F., Frequent detection of Epstein-Barr virus DNA by polymerase chain reaction in lymphnode biopsies from patients with Hodgkin's disease without genomic evidence of B-or T-cell clonality. Blood, 1991, 78, 760.
14. Brousset, P., Schlaifer, D., Meggetto, F., Bachmann, E., Rothenberger, S., Pris, J., Delsol, G. and Knecht, H., Persistence of the same viral strain in early and late relapse of Epstein-Barr virus-associated Hodgkin's disease. Blood, 1994, 84, 2447.
15. Uesugi, Y., Tanno, Y., Tanaka, M., Tanaka, K., Suzuki, T., Inuzuka, T., Ishikawa, T., Toba, K., Koike, T., Shibata, A. and Tsuji, S., Peripheral neuropathy in large granular lymphocytic leukemia. No-To-Shinkei, 1993, 45, 773.
16. Toba, K., Winton, E. F. and Bray, R. A., Improved staining method for the simultaneous flow cytofluorometric analysis of DNA content, S-phase fraction, and surface phenotype using single laser instrumentation. Cytometry, 1992, 13, 60.
17. Zelenin, A. V., Poletaev, A. I., Stepanova, N. G., Barsky, V. E., Kolesnikov, V. A., Nikitin, S. M., Zhuze, A. L. and Gnutchev, N. V., 7-amino-actinomycin D as a specific fluorophore for DNA content analysis by laser flow cytometry. Cytometry, 1984, 5, 348.
18. Muller, W. and Crothers, D. M., Interactions of heteroaromatic compounds with nucleic acids. 1. The influence of heteroatoms and polarizability on the base specificity on intercalating ligands. European Journal of Biochemistry, 1975, 54, 267.
19. Toba, K., Winton, E. F., Koike, T. and Shibata, A., Simultaneous three-color analysis of the surface phenotype and DNA-RNA quantitation using 7-amino-actinomycin-D and Pyronin Y. Journal of Immunological Methods, 1995, 182, 193.
20. Toba, K., Kishi, K., Koike, T., Winton, E. F., Takahashi, H., Nagai, K., Maruyama, S., Furukawa, T., Hashimoto, S., Masuko, M., Uesugi, Y., Kuroha, T., Tsukada, N. and Shibata, A., Classification of cell cycle characterized with DNA/RNA quantitation using 7AAD/PY in hemopoietic malignancy. Experimental Hematology, 1996, 24, 894.
21. Imai, S., Sugiura, M., Oikawa, O., Koizumi, S., Hirao, M., Kimura, H., Hayashibara, H., Terai, N., Tsutsumi, H., Oda, T., Chiba, S. and Osato, T., Epstein-Barr virus (EBV)-carrying and -expressing T-cell lines established from severe chronic active EBV infection. Blood, 1996, 87, 1446.
22. Mohri, S., Kawashima, Y., Uchigata, Y., Seki, H., Okuda, N., Masuda, S. and Fukushiro, R., A case of mosquito hypersensitivity terminating as malignant histiocytosis. Journal of Dermatology, 1982, 9, 437.
23. Shibata, T., Koike, T. and Nakamura, H., Severe pancytopenic episodes in two cases with mosquito-allergy. Japanese Journal of Clinical Hematology, 1990, 31, 999.
24. Ishihara, S., Okada, S., Wakiguchi, H., Kurashige, T., Morishima, T. and Kawa-Ha, K., Chronic active Epstein-Barr virus infection in children in Japan. Acta Paediatrica, 1995,84, 1271.
25. Colby, B. M., Shaw, J. E., Elion, G. B. and Pagano, J. S., Effect of acyclovir (9-(2-hydroxyethoxymethyl) guanine) on Epstein-Barr virus DNA replication. Journal of Virology, 1980, 34, 560.
26. Datta, A. K., Colby, B. M., Shaw, J. E. and Pagano, J. S., Acyclovir inhibition of Epstein-Barr virus replication. Proceedings of the National Academy of Sciences USA, 1980, 77, 5163.
27. Ishida, Y., Yokota, Y., Tauchi, H., Fukuda, M., Takaoka, T., Hayashi, M. and Matsuda, H., Ganciclovir for chronic active Epstein-Barr virus infection. Lancet, 1993, 341, 560.
28. Ohga, S., Matsuzaki, A. and Tokunaga, K., Clonal dissemination of Epstein-Barr (EB) virus in a patient with fatal chronic active EB virus infection. International Journal of Pediatric Hematology/Oncology, 1994, 1, 305.
29. Kawa-Ha, K., Franko, E. and Doi, S., Successful treatment of chronic active Epstein-Barr virus infection with recombinant interleukin-2. Lancet, 154, 1994, i, 1987.
30. Baiocchi, R. A. & Caligiuri, M. A. Low-dose interleukin 2 prevents the development of Epstein-Barr virus (EBV)-associated lymphoproliferative disease in scid/scid mice reconstituted with EBV-seropositive human peripheral blood lymphocytes. Proceedings of the National Academy of Sciences USA, 1994, 91, 5577.
31. Shapiro, R. S., Chauvenet, A., McGuire, W., Pearson, A., Craft, A. W., McGlave, P. and Filipovich, A., Treatment of B-cell lymphoproliferative disorders with interferon-alfa and intravenous gamma globulin [letter]. New England Journal of Medicine, 1988, 318, 1334.
32. Nimer, S. D., Paquette, R. L., Ireland, P., Resta, D., Young, D. and Golde, D. W., A phase I/II study of interleukin-3 in patients with aplastic anemia and myelodysplasia. Experimental Hematology, 1994, 22, 875.
33. Lopez, K. D. and Guinan, E. C., GM-CSF clinical trials: pediatric aplastic anemia and Fanconi's anemia. Pediatric Nursing, 1995, 21, 345.
34. Cortelazzo, S., Viero, P., Bellavita, P., Rossi, A., Buelli, M., Borleri, G. M., Marziali, S., Bassan, R., Comotti, B. and Rambaldi, A., Granulocyte colony-stimulating factor following peripheral-blood progenitor-cell transplant in non-Hodgkin's lymphoma. Journal of Clinical Oncology, 1995, 13, 935.
35. Haas, R., Hohaus, S., Goldschmidt, H., Mohle, R., Witt, B., Wannenmacher, M. and Hunstein, W., High-dose therapy and autografting with peripheral blood stem cells in malignant lymphoma: granulocyte-macrophage colony-stimulating factor for stem cell mobilization. Seminars in Oncology, 6 Suppl. 16, 1994, 21, 19.
36. Hiddemann, W., Wormann, B., Reuter, C., Schleyer, E., Zuhlsdorf, M., Bockmann, A. and Buchner, T., New perspectives in the treatment of acute myeloid leukemia by hematopoietic growth factors [review]. Seminars in Oncology, 6 Suppl. 16, 1994, 21, 33.
37. Richard, C., Baro, J., Bello-Fernandez, C., Hermida, G., Calavia, J., Olalla, I., Alsar, M. J., Loyola, I., Cuadrado, M. A. and Iriondo, A., Recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) administration after autologous bone marrow transplantation for acute myeloblastic leukemia enhances activated killer cell function and may diminish leukemic relapse. Bone Marrow Transplantation, 1995, 15, 721.
38. Dolbeare, F., Gratzner, H., Pallavicini, M. G. and Gray, J. W., Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine. Proceedings of the National Academy of Sciences USA, 1983, 80, 5573.
39. Terry, N. H. A., White, R. A., Meistrich, M. L. and Calkins, D. P., Evaluation of flow cytometric methods for determining population potential doubling times using cultured cells. Cytometry, 1991, 12, 234.
40. Darzynkiewicz, Z., Traganos, F. and Melamed, M. R., New cell cycle compartments identified by multiparameter flow cytometry. Cytometry, 1980, 1, 98.
41. Darzynkiewicz, Z., Sharpless, T., Staiano-Cioco, L. and Melamed, M. R., Subcompartments of the G1 phase of cell cycle detected by flow cytometry. Proceedings of the National Academy of Sciences USA, 1980, 77, 6696.
42. Andreeff, M., Darzynkiewicz, Z., Sharpress, T. K., Clarkson, B. D. and Melamed, M. R., Discrimination of human leukemia subtypes by flow cytometric analysis of cellular DNA and RNA. Blood, 1980, 55, 282.
43. Barlogie, B., Maddox, A. M., Johnston, D. A., Raber, M. N., Drewinko, B., Keating, M. J. and Freireich, E. J., Quantitative cytology in leukemia research [review]. Blood Cells, 1983, 1, 35.
44. Maddox, A. M., Johnston, D. A., Barlogie, B., Youness, E., Keating, M. J. and Freireich, E. J., DNA-RNA measurements in patients with acute leukemia undergoing remission induction therapy. Journal of Clinical Oncology, 1985, 3, 799.
45. Winton, E. F., Bucur, S. Z., Bray, R. A., Toba, K., Williams, D. E., McClure, H. M. and Lyman, S. D., The hematopoietic effects of recombinant human (rh) FLT3 ligand administered to non-human primates. Blood Supplement, 1995, 1, 424a.